Kenya Clinical Nutrition Market Report 2023 to 2030

Kenya Clinical Nutrition Market Analysis

$ 3999

The Kenya Clinical Nutrition Market was valued at $21.5 Mn in 2023 and is projected to grow at a CAGR of 6.44% from 2023 to 2023, to $33.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nutrivea, Healthwise Kenya, Haltons Pharmacy, Mead Johnson & Company, GSK, Unilever among others.

ID: IN10KEPH569 CATEGORY: Pharmaceuticals GEOGRAPHY: Kenya AUTHOR: Mahima Reddy

Buy Now

Kenya Clinical Nutrition Market Executive Summary

The Kenya Clinical Nutrition Market is at around $21.5 Mn in 2023 and is projected to reach $33.2 Mn in 2030, exhibiting a CAGR of 6.44% during the forecast period 2023-2030.

Clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The clinical nutrition sector is undergoing a transformation fuelled by progress in medical research and technology. Key trends such as innovative formulations, personalized nutrition solutions, and the use of bioactive ingredients are emerging. Manufacturers are dedicating resources to R&D to produce products that not only fulfil fundamental nutritional requirements but also provide added health advantages. This emphasis on innovation is fostering competition among industry participants, resulting in a constant flow of new products and therapies tailored to various patient demographics.

Clinical nutritionists or registered dietitians work in hospitals, clinics, and other healthcare facilities to, assess patients' nutritional status, develop personalized nutrition plans, provide nutrition education, manage nutrition-related diseases like diabetes, malnutrition etc, support optimal health and well-being. Some areas of focus in clinical nutrition include, critical care nutrition, paediatric nutrition, oncology nutrition, gastrointestinal nutrition, sports nutrition etc.

Kenya is experiencing a rise in the prevalence of non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and cancer. The prevalence of diabetes among adults in Kenya was 2.4% in 2019, up from 1.8% in 2000.The age-standardized prevalence of hypertension in Kenya was 24.5% in 2015. The major drivers of Clinical Nutrition industry in Kenya are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

The industry is primarily dominated by players such as Nutrivea, Healthwise Kenya, Haltons Pharmacy, Mead Johnson & Company, GSK, Unilever among others.

Kenya Clinical Nutrition Market Report 2023 to 2030

Market Dynamics

Market Drivers

Increasing Prevalence of Chronic Diseases: Kenya is experiencing a rise in the prevalence of non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and cancer. The prevalence of diabetes among adults in Kenya was 2.4% in 2019, up from 1.8% in 2000.The age-standardized prevalence of hypertension in Kenya was 24.5% in 2015. The growing burden of chronic conditions like diabetes and cardiovascular diseases is driving the demand for specialized clinical nutrition products.

Malnutrition Burden: Kenya faces a significant burden of malnutrition, with high rates of undernutrition, micronutrient deficiencies, and stunting among children. In Kenya, 26% of children under the age of 5 are stunted, and 4% are wasted, indicating acute undernutrition. The prevalence of anaemia among women of reproductive age is 27.2%. The high rates of malnutrition, both undernutrition and micronutrient deficiencies, are a major driver for the clinical nutrition market.

Government Initiatives: The Kenyan government has implemented the National Nutrition Action Plan 2018-2022 to address malnutrition and promote optimal nutrition. This plan includes strategies to strengthen the delivery of nutrition services and increase access to nutritious foods. These policy efforts are supporting the growth and development of the clinical nutrition market.

Market Restraints

Limited Healthcare Infrastructure: Kenya faces challenges in terms of the availability and accessibility of healthcare facilities, especially in rural areas. This can hinder the reach and adoption of clinical nutrition products and services.

Economic Factors: The high cost of specialized clinical nutrition products can be a barrier to their adoption, especially for lower-income populations. This can limit the affordability and accessibility of these products.

Lack of Awareness: Despite the growing awareness, there may still be a lack of understanding among the general population regarding the importance of clinical nutrition, especially for managing chronic health conditions is hampering the market growth of clinical nutrition market. Addressing this knowledge gap is crucial for market growth.

Regulatory Landscape and Reimbursement Scenario

Clinical nutrition regulation and reimbursement in Kenya are managed through a system involving several governmental bodies, primarily under the oversight of the Ministry of Health. The Kenya Bureau of Standards (KEBS) plays a crucial role in setting and enforcing standards for food products, including clinical nutrition formulations. The Pharmacy and Poisons Board (PPB) regulates pharmaceutical products, which may include certain clinical nutritional supplements classified as drugs. The regulation of clinical nutrition products in Kenya is not as clearly defined as in some more developed countries, with many products falling into a gray area between food and drug classifications.

The Food, Drugs and Chemical Substances Act provides the primary legal framework for regulating these products. Reimbursement for clinical nutrition in Kenya is limited and fragmented. The National Hospital Insurance Fund (NHIF) provides some coverage for inpatient nutritional support, but outpatient nutritional therapies are often not covered, leading to significant out-of-pocket expenses for patients. Private health insurance plans may offer more comprehensive coverage, but these are accessible to only a small portion of the population.

The Kenya Medical Research Institute (KEMRI) and professional bodies like the Kenya Nutritionists and Dieticians Institute (KNDI) play important roles in developing guidelines and influencing policies related to clinical nutrition.

Competitive Landscape

Key Players

Here are some of the major key players in the Kenya Clinical Nutrition Market:

Nutrivea
Healthwise Kenya
Haltons Pharmacy
Unilever
GSK
Pfizer
Jambo Superfoods
GNC
GlaxoSmithKline
Nestle
Mead Johnson & Company, LLC

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Kenya Clinical Nutrition Market Segmentation

By Product

Oral Clinical Nutrition
Parenteral Nutrition
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins & Minerals
Enteral Feeding Formulas
Standard Formula
Disease-specific Formulas
Others

By Application

Alzheimer’s Disease
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Retail Sales Channels
Online Sales Channels
Institutional Sales Channels
Others

End Users

Geriatric
Adults
Paediatric

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.